Credit: CC0 Public Domain

India began one of the world’s biggest coronavirus vaccination programmes on Saturday, hoping to end a pandemic that has killed 150,000 people in the country and torpedoed the economy.

AFP looks at the numbers involved in the vast and complex undertaking compounded by weak infrastructure, online hoaxes and worries about one of the vaccines being rolled out while still in .

300 million people

Over the coming months, India aims to inoculate around a quarter of the population, or 300 million people. They include healthcare workers, people aged over 50 and those at high

With a little help for its rivals

Sanofi, France’s biggest pharmaceutical company, could help produce foreign-developed COVID-19 vaccines pending the launch of its own vaccine, which will not be ready for months, a government minister said Friday.

Industry Minister Agnes Pannier-Runacher told Radio Classique that vaccines developed by BioNTech, which partners with Pfizer, and Janssen, owned by Johnson and Johnson, were the most likely choices for Sanofi to lend a helping hand.

The world has been scrambling to develop and produce enough anti-COVID vaccines, with innoculation drives hampered by limited stocks of doses and logistical constraints.

France had high hopes